Matilda S
Posted by

Talented young Cardiff scientist wins prestigious leukaemia award

Matilda S
Posted by
28 Mar 2011

Leukaemia & Lymphoma Research scientist Dr Thet Thet Lin from the University of Cardiff has been awarded the prestigious Hamblin Award 2010 for research breakthroughs in chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults.

The annual Hamblin Award, which is presented once per year, recognises a UK based scientist who has carried a significant piece of research into CLL that year.

Dr Lin comments, “I am delighted to have won this award. I am very proud to be part of such a fantastic Leukaemia & Lymphoma Research team who are dedicated to improving treatments for patients with leukaemia.”

Dr Lin is part of a Leukaemia & Lymphoma Research team at the University of Cardiff whose research is focused on developing potential drugs and translating breakthroughs into new treatments for patients with leukaemia.

Dr Lin’s award winning research, which was published in the journal Blood in December 2010, provided important new insights into how chronic lymphocytic leukaemia progresses.

In particular, this research looked at areas at the end of chromosomes, called telomeres that protect the DNA carried on the chromosomes and help to prevent genetic mutations that can lead to cancer. Understanding how telomeres cause leukaemia and how they can be targeted with new drugs is essential to improving treatments.  

Drs Chris Pepper and Duncan Baird from the University of Cardiff who co-lead Dr Lin’s research project add, “Thet is an incredibly dedicated researcher, who is determined to improve treatments for patients with leukaemia. This award is greatly deserved and recognises the fantastic contribution Thet makes to our research. These findings will allow us to improve the way treatments are delivered to patients with chronic lymphocytic leukaemia”.

The Hamblin Award was presented to Dr Thet Thet Lin by leading CLL researcher Professor Andrew Pettitt at a recent UK CLL Forum in London in March 2011.